Laurus Labs [LAURUSLABS] vs Lupin [LUPIN] Detailed Stock Comparison

Laurus Labs Ltd.

NSE
Loading...

Lupin Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Laurus Labs Ltd. wins in 2 metrics, Lupin Ltd. wins in 18 metrics, with 0 ties. Lupin Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Laurus Labs Ltd. Lupin Ltd. Better
P/E Ratio (TTM) 70.26 22.74 Lupin Ltd.
Price-to-Book Ratio 12.32 5.37 Lupin Ltd.
Debt-to-Equity Ratio 44.83 31.51 Lupin Ltd.
PEG Ratio 0.06 0.60 Laurus Labs Ltd.
EV/EBITDA 37.60 15.38 Lupin Ltd.
Profit Margin (TTM) 12.55% 17.76% Lupin Ltd.
Operating Margin (TTM) 20.22% 26.46% Lupin Ltd.
EBITDA Margin (TTM) 20.22% 26.46% Lupin Ltd.
Return on Equity 7.79% 18.98% Lupin Ltd.
Return on Assets (TTM) 3.84% 11.24% Lupin Ltd.
Free Cash Flow (TTM) $-393.50M $13.18B Lupin Ltd.
Dividend Yield 0.21% 0.62% Lupin Ltd.
1-Year Return 109.17% 14.69% Laurus Labs Ltd.
Price-to-Sales Ratio (TTM) 8.81 4.03 Lupin Ltd.
Enterprise Value $623.27B $1,054.33B Lupin Ltd.
EV/Revenue Ratio 9.27 4.03 Lupin Ltd.
Gross Profit Margin (TTM) 60.94% 73.55% Lupin Ltd.
Revenue per Share (TTM) $125 $573 Lupin Ltd.
Earnings per Share (Diluted) $15.60 $101.47 Lupin Ltd.
Beta (Stock Volatility) 0.34 0.28 Lupin Ltd.

Laurus Labs Ltd. vs Lupin Ltd. Stock Performance Analysis

Loading Price Chart...

LAURUSLABS
LUPIN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Laurus Labs Ltd.-0.37%-1.11%4.95%44.58%38.23%25.10%
Lupin Ltd.-0.88%0.83%-0.14%-0.76%8.63%8.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Laurus Labs Ltd.109.17%278.94%134.91%1,365.68%1,365.68%1,365.68%
Lupin Ltd.14.69%176.15%98.45%56.65%418.49%2,332.69%

Performance & Financial Health Analysis: Laurus Labs Ltd. vs Lupin Ltd.

MetricLAURUSLABSLUPIN
Market Information
Market Cap i₹609.64B₹1.07T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,449,9891,119,327
90 Day Avg. Volume i1,817,1911,057,063
Last Close₹1,389.10₹2,273.10
52 Week Range₹641.05 - ₹1,457.00₹1,836.80 - ₹2,494.00
% from 52W High-4.66%-8.86%
All-Time High₹1,457.00 (Jun 08, 2026)₹2,459.00 (May 06, 2026)
% from All-Time High-4.66%-7.56%
Growth Metrics
Quarterly Revenue Growth0.26%0.24%
Quarterly Earnings Growth1.73%0.38%
Financial Health
Profit Margin (TTM) i0.13%0.18%
Operating Margin (TTM) i0.20%0.26%
Return on Equity (TTM) i0.08%0.19%
Debt to Equity (MRQ) i44.8331.51
Cash & Liquidity
Book Value per Share (MRQ)₹88.98₹429.87
Cash per Share (MRQ)₹1.18₹137.55
Operating Cash Flow (TTM) i₹4.13B₹28.04B
Levered Free Cash Flow (TTM) i₹3.58B₹32.82B
Dividends
Last 12-Month Dividend Yield i0.21%0.62%
Last 12-Month Dividend i₹2.00₹12.00

Valuation & Enterprise Metrics Analysis: Laurus Labs Ltd. vs Lupin Ltd.

MetricLAURUSLABS (Apr 24, 2026)LUPIN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i70.2622.74
Forward P/E i58.8023.46
PEG Ratio i0.060.60
Price to Sales (TTM) i8.814.03
Price to Book (MRQ) i12.325.37
Market Capitalization
Market Capitalization i₹609.64B₹1.07T
Enterprise Value i₹623.27B₹1.05T
Enterprise Value Metrics
Enterprise to Revenue i9.274.03
Enterprise to EBITDA i37.6015.38
Risk & Other Metrics
Beta i0.340.28
Book Value per Share (MRQ) i₹88.98₹429.87

Financial Statements Comparison: Laurus Labs Ltd. vs Lupin Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLAURUSLABS (2025)LUPIN (2025)
Revenue/Sales i55.08B221.92B
Cost of Goods Sold i25.39B74.56B
COGS % of Revenue i46.1%33.6%
Gross Profit i29.68B147.36B
Gross Margin i53.9%66.4%
Research & Development i553.00MN/A
Operating Income (EBIT) i6.25B43.45B
Operating Margin i11.4%19.6%
EBITDA i10.64B56.45B
EBITDA Margin i19.3%25.4%
Pre-Tax Income i4.84B40.15B
Pre-Tax Income % of Revenue i8.8%18.1%
Income Tax i1.30B7.09B
Income Tax % of Revenue i2.4%3.2%
Net Income (Profit) i3.58B33.06B
Profit Margin i6.5%14.9%

Balance Sheet & Liquidity Metrics

MetricLAURUSLABS (2025)LUPIN (2025)
Cash & Equivalents i995.40M19.31B
Total Current Assets i43.32B167.99B
Total Current Assets % of Revenue i78.7%75.7%
Total Current Liabilities i35.40B89.61B
Total Current Liabilities % of Revenue i64.3%40.4%
Long-Term Debt i7.08B20.31B
Long-Term Debt % of Revenue i12.9%9.1%
Total Shareholders Equity i46.03B172.94B
Retained Earnings i36.26B140.71B
Retained Earnings % of Revenue i65.8%63.4%
Property, Plant & Equipment i1.89B84.20M

Cash Flow Statement Comparison

MetricLAURUSLABS (2025)LUPIN (2025)
Operating Cash Flow i4.13B28.04B
Operating Cash Flow % of Revenue i7.5%12.6%
Capital Expenditures i-5.41B-16.53B
Free Cash Flow i-393.50M13.18B
FCF Margin i-0.7%5.9%
Debt Repayment i-3.16B0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLAURUSLABSLUPIN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i539.86M457.18M
Float Shares i362.63M241.86M
% Held by Insiders i32.06%47.03%
% Held by Institutions i34.74%34.14%
% Held by Public i33.20%18.83%

Dividend Analysis & Yield Comparison: Laurus Labs Ltd. vs Lupin Ltd.

MetricLAURUSLABSLUPIN
Last 12-Month Dividend i₹2.00₹12.00
Last 12-Month Dividend Yield i0.21%0.62%
3-Year Avg Annual Dividend i₹1.60₹8.00
3-Year Avg Dividend Yield i0.15%0.50%
3-Year Total Dividends i₹4.80₹24.00
Ex-Dividend DateOct 31, 2025Jul 25, 2025